Randomized Clinical Trial of Efficacy and Safety of a Single 2‐mg Intravenous Dose of Hydromorphone Versus Usual Care in the Management of Acute Pain
Objectives The objective was to test the efficacy and safety of 2 mg of intravenous (IV) hydromorphone (Dilaudid) against “usual care” in emergency department (ED) patients with acute severe pain. Methods This was a randomized clinical trial. Patients allocated to 2 mg of IV hydromorphone received t...
Gespeichert in:
Veröffentlicht in: | Academic emergency medicine 2013-02, Vol.20 (2), p.185-192 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!